DK1781814T3 - Fremgangsmåder og kit til prognose af brystkræft - Google Patents

Fremgangsmåder og kit til prognose af brystkræft

Info

Publication number
DK1781814T3
DK1781814T3 DK05763127.7T DK05763127T DK1781814T3 DK 1781814 T3 DK1781814 T3 DK 1781814T3 DK 05763127 T DK05763127 T DK 05763127T DK 1781814 T3 DK1781814 T3 DK 1781814T3
Authority
DK
Denmark
Prior art keywords
breast cancer
likelihood
patient
molecular
prognosis
Prior art date
Application number
DK05763127.7T
Other languages
English (en)
Inventor
Wen Guo Jiang
Original Assignee
Cardiff Biolog Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0417740A external-priority patent/GB0417740D0/en
Priority claimed from GB0426777A external-priority patent/GB0426777D0/en
Application filed by Cardiff Biolog Ltd filed Critical Cardiff Biolog Ltd
Application granted granted Critical
Publication of DK1781814T3 publication Critical patent/DK1781814T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Prostheses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK05763127.7T 2004-08-10 2005-07-27 Fremgangsmåder og kit til prognose af brystkræft DK1781814T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0417740A GB0417740D0 (en) 2004-08-10 2004-08-10 Methods and kit for the prognosis of breast cancer
GB0426777A GB0426777D0 (en) 2004-12-07 2004-12-07 Methods and kit for the prognosis of breast cancer
PCT/GB2005/002971 WO2006016110A1 (en) 2004-08-10 2005-07-27 Methods and kit for the prognosis of breast cancer

Publications (1)

Publication Number Publication Date
DK1781814T3 true DK1781814T3 (da) 2010-05-03

Family

ID=35044601

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05763127.7T DK1781814T3 (da) 2004-08-10 2005-07-27 Fremgangsmåder og kit til prognose af brystkræft

Country Status (15)

Country Link
US (1) US20100035240A1 (da)
EP (1) EP1781814B3 (da)
JP (2) JP5117852B2 (da)
CN (1) CN102443627B (da)
AT (1) ATE454474T1 (da)
AU (1) AU2005271113B2 (da)
CA (1) CA2576113A1 (da)
DE (1) DE602005018789D1 (da)
DK (1) DK1781814T3 (da)
ES (1) ES2339132T7 (da)
GB (1) GB2430741A (da)
HK (1) HK1103422A1 (da)
MX (1) MX2007001640A (da)
PT (1) PT1781814E (da)
WO (1) WO2006016110A1 (da)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8497292B2 (en) 2005-12-28 2013-07-30 Translational Therapeutics, Inc. Translational dysfunction based therapeutics
KR100786759B1 (ko) * 2006-07-07 2007-12-18 김현기 Ｈｃｃｒ-1을 포함하는 유방암 예후 마커 및 비만 유도조성물
CN1919874B (zh) * 2006-09-18 2010-09-08 中国人民解放军军事医学科学院生物工程研究所 一种抗尿激酶型纤溶酶激活剂受体的抗体样分子ATF-Fc融合蛋白及其用途
CA2664712C (en) * 2006-09-29 2019-07-09 Translational Therapeutics, Inc. Eif4e regulon-based diagnostics
WO2008138868A2 (en) * 2007-05-09 2008-11-20 Traslational Cancer Drugs Pharma, S.L. In vitro diagnosis and/or prognosis of cancer by the analysis of gtpase protein expression
WO2008150512A2 (en) * 2007-06-04 2008-12-11 University Of Louisville Research Foundation, Inc. Methods for identifying an increased likelihood of recurrence of breast cancer
ES2338843B1 (es) * 2008-07-02 2011-01-24 Centro De Investigaciones Energeticas, Medioambientales Y Tecnologicas Huella genomica de cancer de mama.
US20100081666A1 (en) * 2008-07-14 2010-04-01 Wyeth Src activation for determining cancer prognosis and as a target for cancer therapy
US8735082B2 (en) 2008-11-10 2014-05-27 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Gene signature for predicting prognosis of patients with solid tumors
GB0821787D0 (en) * 2008-12-01 2009-01-07 Univ Ulster A genomic-based method of stratifying breast cancer patients
WO2010128158A1 (en) * 2009-05-08 2010-11-11 Novartis Ag Diagnostic biomarkers for fibrotic disorders
WO2011122857A2 (ko) * 2010-03-30 2011-10-06 서울대학교 산학협력단 유방암 예후 예측을 위한 조성물 및 이를 포함하는 키트
JP2014515821A (ja) * 2011-03-27 2014-07-03 オンコステム ダイアグノスティックス（モーリシャス）プライベート リミテッド 腫瘍細胞を同定するためのマーカー、その方法およびキット
WO2012178128A1 (en) * 2011-06-22 2012-12-27 Oncocyte Corporation Methods and compositions for the treatment and diagnosis of cancer
CA2844793A1 (en) * 2011-08-31 2013-03-07 Oncocyte Corporation Methods and compositions for the treatment and diagnosis of cancer
CN104685065B (zh) 2012-01-20 2017-02-22 俄亥俄州立大学 浸润性和预后的乳腺癌生物标志物标签
FR2988479B1 (fr) * 2012-03-23 2014-12-19 Hospices Civils Lyon Procede de determination de la susceptibilite aux infections nosocomiales
KR101672531B1 (ko) * 2013-04-18 2016-11-17 주식회사 젠큐릭스 조기 유방암 예후 예측 진단용 유전자 마커 및 이의 용도
CN103235141A (zh) * 2013-04-27 2013-08-07 上海交通大学医学院附属新华医院 Atf3用于预测膀胱癌转移和判断预后的应用
KR101548830B1 (ko) * 2013-12-30 2015-08-31 가천대학교 산학협력단 줄기세포 배양방법을 이용하여 발굴된 유방암 줄기세포 마커를 이용한 유방암 예후 예측용 조성물
JP6711968B2 (ja) * 2014-01-10 2020-06-17 学校法人順天堂 子宮体がんのリンパ節転移能の評価方法
CA2947198C (en) * 2014-04-29 2023-01-17 Novartis Ag Novel vertebrate cells and methods for recombinantly expressing a polypeptide of interest
CN105986024B (zh) * 2015-02-27 2019-10-25 复旦大学附属肿瘤医院 一组用于三阴性乳腺癌预后的基因及其应用
CN104725487A (zh) * 2015-04-06 2015-06-24 苏州普罗达生物科技有限公司 紧密连接蛋白抑制剂多肽及其应用
CN104725488A (zh) * 2015-04-06 2015-06-24 苏州普罗达生物科技有限公司 关于紧密连接蛋白抑制剂多肽及其应用
CN106295244B (zh) * 2015-06-05 2019-09-17 上海交通大学医学院附属瑞金医院 肿瘤诊断标志物的筛选方法、以该方法获得的乳腺癌肺转移相关基因及其应用
SG11201707815RA (en) 2015-06-05 2017-12-28 Novartis Ag Antibodies targeting bone morphogenetic protein 9 (bmp9) and methods therefor
WO2017007031A1 (ja) * 2015-07-09 2017-01-12 学校法人順天堂 子宮体がんのリンパ節転移能の評価方法
CN106337081B (zh) * 2016-02-02 2020-01-21 中国医学科学院肿瘤医院 FABP4基因的SNP位点rs1054135与三阴型乳腺癌预后的相关性
WO2018074865A2 (ko) * 2016-10-21 2018-04-26 서울대학교병원 유방암 예후 예측용 조성물 및 방법
EP3364190A1 (en) * 2017-02-20 2018-08-22 Panka Cancer Research AG Method of detecting cancer or cancer cells
TW201834698A (zh) * 2017-03-03 2018-10-01 國立研究開發法人國立癌症研究中心 抗ｉｌ－７ｒ抗體之抗體藥物共軛物與處置癌或發炎用之包含抗ｉｌ－７ｒ抗體與細胞傷害劑之抗體藥物共軛物之醫藥組成物
CN108504726B (zh) * 2018-03-28 2021-10-26 华南农业大学 采用amf单个孢子微量dna进行pcr预处理的方法
WO2020008097A2 (es) * 2018-07-03 2020-01-09 Universidad De Granada Método de obtención de datos útiles para predecir o pronosticar la supervivencia global y la supervivencia libre de recaídas en el cáncer y composición capaz de modular la actividad de atf4 para el tratamiento del cáncer
CN109620832B (zh) * 2019-01-14 2021-01-01 大连大学 甘氨胆酸在制备抗乳腺增生药物中的应用
KR102280672B1 (ko) * 2019-12-20 2021-07-23 주식회사 베르티스 암의 진단용 조성물
CN114758773A (zh) * 2022-05-25 2022-07-15 四川大学华西医院 一种膀胱癌免疫治疗生物标志物、免疫风险模型及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5759791A (en) * 1989-01-17 1998-06-02 The Johns Hopkins University Cancer related antigen
CA2164498C (en) * 1993-07-09 2007-09-11 Paul A. Price Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices
CA2279575A1 (en) * 1997-02-06 1998-08-13 Genetics Institute, Inc. Human sdf-5 protein and compositions
AU2351699A (en) * 1998-01-30 1999-08-16 Brigham And Women's Hospital The human calcium-sensing receptor in the detection and treatment of cancer
AU1616700A (en) * 1998-11-13 2000-06-05 Curis, Inc. Methods of alleviating cancer symptoms
WO2002059377A2 (en) * 2001-01-24 2002-08-01 Protein Design Labs Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer
US20030064384A1 (en) * 2001-04-02 2003-04-03 Mien-Chie Hung Beta-catenin is a strong and independent prognostic factor for cancer
US20040086504A1 (en) * 2001-06-21 2004-05-06 Deepak Sampath Cyr61 as a target for treatment and diagnosis of breast cancer
WO2003050307A1 (en) * 2001-12-05 2003-06-19 Genzyme Corporation Compounds for therapy and diagnosis and methods for using same
WO2003054165A2 (en) * 2001-12-20 2003-07-03 The Regents Of The University Of California Genetic markers and methods for the diagnosis, treatment and prevention of tumor metastasis
US20030186248A1 (en) * 2002-03-29 2003-10-02 Erlander Mark G. Interpreting cytological specimens via molecular histological signatures
US20040231909A1 (en) * 2003-01-15 2004-11-25 Tai-Yang Luh Motorized vehicle having forward and backward differential structure

Also Published As

Publication number Publication date
EP1781814B3 (en) 2011-08-31
HK1103422A1 (en) 2007-12-21
CN102443627A (zh) 2012-05-09
JP2008508895A (ja) 2008-03-27
GB0701676D0 (en) 2007-03-14
JP5634360B2 (ja) 2014-12-03
DE602005018789D1 (de) 2011-05-26
AU2005271113B2 (en) 2010-12-09
ES2339132T7 (es) 2012-03-16
WO2006016110A1 (en) 2006-02-16
JP5117852B2 (ja) 2013-01-16
WO2006016110A8 (en) 2006-08-24
EP1781814B1 (en) 2010-01-06
ES2339132T3 (es) 2010-05-17
CA2576113A1 (en) 2006-02-16
MX2007001640A (es) 2007-07-25
JP2012024095A (ja) 2012-02-09
CN102443627B (zh) 2014-10-29
ATE454474T1 (de) 2010-01-15
EP1781814A1 (en) 2007-05-09
PT1781814E (pt) 2010-04-12
US20100035240A1 (en) 2010-02-11
AU2005271113A1 (en) 2006-02-16
GB2430741A (en) 2007-04-04

Similar Documents

Publication Publication Date Title
DK1781814T3 (da) Fremgangsmåder og kit til prognose af brystkræft
Kim et al. A nineteen gene-based risk score classifier predicts prognosis of colorectal cancer patients
Luo et al. Dynamic Alu methylation during normal development, aging, and tumorigenesis
Kozak et al. Functional and population genomic divergence within and between two species of killifish adapted to different osmotic niches
Chen et al. TOP2A, HELLS, ATAD2, and TET3 are novel prognostic markers in renal cell carcinoma
DE602005009406D1 (de) Computerimplementiertes verfahren und computergestütztes system zur validierung von dna-sequenzierungsdaten
WO2005116259A3 (en) Use of gene expression profiling to predict survival in cancer patient
Ning et al. Characterization of the Merkel cell carcinoma miRNome
Schramm et al. Next‐generation RNA sequencing reveals differential expression of MYCN target genes and suggests the mTOR pathway as a promising therapy target in MYCN‐amplified neuroblastoma
Shah et al. The landscape of alternative splicing in buccal mucosa squamous cell carcinoma
WO2008117314A3 (en) Genetic variants on chr2 and chr16 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment
WO2008031839A3 (en) Gene expression signature for the prognosis, diagnosis, and therapy of prostate cancer and uses thereof
DK1730315T3 (da) Polymorphismer i NOD2/Card15 gen
Baumgart et al. A miRNA catalogue and ncRNA annotation of the short-living fish Nothobranchius furzeri
EP1898803A4 (en) MOLECULAR / GENETIC ABERRATIONS DETECTED IN THE SURGICAL MARGINS OF A REPRESENTED PANCREATIC CANCER REPRESENTING A NEOPLASTIC DISEASE CORRESPONDING TO THE EVOLUTION OF DISEASE
Lin et al. The potential role of Alu Y in the development of resistance to SN38 (Irinotecan) or oxaliplatin in colorectal cancer
Zhang et al. Association of miR‐1247‐5p expression with clinicopathological parameters and prognosis in breast cancer
WO2014173905A3 (en) Methods and kits for prognosis of stage i nsclc by determining the methylation pattern of cpg dinucleotides
ATE513929T1 (de) Gene mit einfluss auf die menschliche gedächtnisleistung
Veith et al. Cracking the nut: Geographical adjacency of sister taxa supports vicariance in a polytomic salamander clade in the absence of node support
RU2016131028A (ru) Композиции, содержащие асимметричную интерферирующую рнк, которые подвергают сайленсингу k-ras, и способы их применения
CN108174608B (zh) 用于确定患有i期和ii期透明细胞型肾癌瘤的肾癌患者的复发风险的预后方法以及其试剂盒
Diepenbroek et al. Genetic and phylogeographic evidence for Jewish Holocaust victims at the Sobibór death camp
Semik-Gurgul et al. DNA methylation patterns of the S100A14, POU2F3 and SFN genes in equine sarcoid tissues
ATE530668T1 (de) Verfahren und kits zur brustkrebsprognose